Nutragen Pharma Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 24-07-2024
- Paid Up Capital ₹ 3.00 Cr
as on 24-07-2024
- Company Age 19 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.40 M
as on 24-07-2024
- Satisfied Charges ₹ 1.49 Cr
as on 24-07-2024
- Revenue 9.33%
(FY 2023)
- Profit -76.09%
(FY 2023)
- Ebitda 30.46%
(FY 2023)
- Net Worth 98.50%
(FY 2023)
- Total Assets 14.54%
(FY 2023)
About Nutragen Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹4.40 M. The company has closed loans amounting to ₹1.49 Cr, as per Ministry of Corporate Affairs (MCA) records.
Neelakantan Babu, Sujayababu Jayasankar, and Padmini Sankaran serve as directors at the Company.
- CIN/LLPIN
U24232TN2005PTC056577
- Company No.
056577
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jun 2005
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Nutragen Pharma Private Limited offer?
Nutragen Pharma Private Limited offers a wide range of products and services, including Pharmaceutical Capsules, Softgel Capsules, Nutraceuticals & Dietary Supplements, Dietary Supplements.
Who are the key members and board of directors at Nutragen Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sujayababu Jayasankar  | Managing Director | 10-Jun-2005 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Neelakantan Babu | Director | 10-Jun-2005 | Current |
| Padmini Sankaran | Director | 16-Jan-2009 | Current |
Financial of Nutragen Pharma.
Nutragen Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.33% increase. The company also saw a substantial fall in profitability, with a 76.09% decrease in profit. The company's net worth Soared by an impressive increase of 98.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nutragen Pharma?
In 2023, Nutragen Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bharathy Minerals Private LimitedActive 9 years 8 monthsNeelakantan Babu, Sujayababu Jayasankar and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The South Indian Bank Limited Creation Date: 30 Sep 2021 | ₹4.40 M | Open |
State Bank Of Travancore Creation Date: 21 Dec 2006 | ₹1.49 Cr | Satisfied |
How Many Employees Work at Nutragen Pharma?
Unlock and access historical data on people associated with Nutragen Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nutragen Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nutragen Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
